Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascale Varlet

Showing results (31-40 of 248) with videos related to

Pageof 25
Sort By:
Pediatric Blood & Cancer|December 31, 2013
Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomasFrancisco Bautista, Angelo Paci, Veronique Minard-Colin, et al.
Pharmaceutics|May 1, 2020
Characterization of the Blood-Brain Barrier Integrity and the Brain Transport of SN-38 in an Orthotopic Xenograft Rat Model of Diffuse Intrinsic Pontine GliomaCatarina Chaves, Xavier Declèves, Meryam Taghi, et al.
Brain Tumor Pathology|September 15, 2022
An extracranial CNS presentation of the emerging "intracranial" mesenchymal tumor, FET: CREB-fusion positiveArnault Tauziède-Espariat, Gaëlle Pierron, Delphine Guillemot, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|June 20, 2008
GFAPdelta immunostaining improves visualization of normal and pathologic astrocytic heterogeneityFelipe Andreiuolo, Marie-Pierre Junier, Elly M Hol, et al.
Neurology|November 29, 2013
White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy?Andreas Charidimou, Zane Jaunmuktane, Jean-Claude Baron, et al.
Acta Neuropathologica Communications|May 22, 2019
H3F3A-G34R mutant high grade neuroepithelial neoplasms with glial and dysplastic ganglion cell componentsFelipe Andreiuolo, Tomo Lisner, Jozef Zlocha, et al.
Neuro-Oncology Advances|December 2, 2024
Watch-and-wait approach versus adjuvant treatment after radical awake resection in selected adult-type grade 3 gliomas, <i>isocitrate dehydrogenase</i> mutant: A case-matched cohortAngela Elia, Alexandre Roux, Bénédicte Trancart, et al.
Neuro-Oncology|June 18, 2013
Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomasChloé Gerin, Johan Pallud, Christophe Deroulers, et al.
Virchows Archiv : an International Journal of Pathology|October 28, 2022
All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutantThibaut Wolf, Andres Hugo Coca, Noelle Weingertner, et al.
Journal of Neuro-Oncology|August 23, 2011
Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine gliomaAndrea Chassot, Sandra Canale, Pascale Varlet, et al.
Pageof 25

Showing results (31-40 of 248) with videos related to

Sort By:
Pageof 25
Pediatric Blood & Cancer|December 31, 2013
Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomasFrancisco Bautista, Angelo Paci, Veronique Minard-Colin, et al.
Pharmaceutics|May 1, 2020
Characterization of the Blood-Brain Barrier Integrity and the Brain Transport of SN-38 in an Orthotopic Xenograft Rat Model of Diffuse Intrinsic Pontine GliomaCatarina Chaves, Xavier Declèves, Meryam Taghi, et al.
Brain Tumor Pathology|September 15, 2022
An extracranial CNS presentation of the emerging "intracranial" mesenchymal tumor, FET: CREB-fusion positiveArnault Tauziède-Espariat, Gaëlle Pierron, Delphine Guillemot, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|June 20, 2008
GFAPdelta immunostaining improves visualization of normal and pathologic astrocytic heterogeneityFelipe Andreiuolo, Marie-Pierre Junier, Elly M Hol, et al.
Neurology|November 29, 2013
White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy?Andreas Charidimou, Zane Jaunmuktane, Jean-Claude Baron, et al.
Acta Neuropathologica Communications|May 22, 2019
H3F3A-G34R mutant high grade neuroepithelial neoplasms with glial and dysplastic ganglion cell componentsFelipe Andreiuolo, Tomo Lisner, Jozef Zlocha, et al.
Neuro-Oncology Advances|December 2, 2024
Watch-and-wait approach versus adjuvant treatment after radical awake resection in selected adult-type grade 3 gliomas, <i>isocitrate dehydrogenase</i> mutant: A case-matched cohortAngela Elia, Alexandre Roux, Bénédicte Trancart, et al.
Neuro-Oncology|June 18, 2013
Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomasChloé Gerin, Johan Pallud, Christophe Deroulers, et al.
Virchows Archiv : an International Journal of Pathology|October 28, 2022
All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutantThibaut Wolf, Andres Hugo Coca, Noelle Weingertner, et al.
Journal of Neuro-Oncology|August 23, 2011
Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine gliomaAndrea Chassot, Sandra Canale, Pascale Varlet, et al.
Pageof 25